Author: Gross-Goupil Marine Bernhard Jean-Christophe Ravaud Alain
Publisher: Informa Healthcare
ISSN: 1354-3784
Source: Expert Opinion on Investigational Drugs, Vol.21, Iss.11, 2012-11, pp. : 1727-1732
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Everolimus: In Advanced Renal Cell Carcinoma
By Garnock-Jones Karly P. Keating Gillian M.
Drugs, Vol. 69, Iss. 15, 2009-10 ,pp. :
Emerging drugs for renal cell carcinoma
By Varella Leticia Rini Brian I
Expert Opinion on Emerging Drugs, Vol. 15, Iss. 3, 2010-09 ,pp. :
Adjuvant treatment for renal cell carcinoma
By Lam John S Belldegrun Arie S Figlin Robert A
Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 6, 2006-04 ,pp. :
Emerging drugs for renal cell carcinoma
By Shaheen Philip E Bukowski Ronald M
Expert Opinion on Emerging Drugs, Vol. 10, Iss. 4, 2005-11 ,pp. :